<p>The Breast Cancer Genome Guided Therapy Study (BEAUTY) is a prospective neoadjuvant clinical study enrolling 140 women with Stage I-III breast cancer. The goals of this study were to 1) perform comprehensive sequencing of germline and tumor tissues (exome and RNA seq), 2) identify genomic alterations and perturbed pathways associated with response/resistance to standard chemotherapy, and 3) develop patient-derived xenograft (PDX) for testing of therapeutic regimens chosen on the basis of alterations identified by genetic sequencing.</p>

Breast Cancer Genome Guided Therapy Study (BEAUTY)

Breast Neoplasms study with RNA-Seq, WXS data on dbGaP (118 participants)

Breast Cancer Genome Guided Therapy Study (BEAUTY)

Description

Applying For Access

Summary